Delays in Filling Clopidogrel Prescription After Hospital Discharge and Adverse Outcomes After Drug-Eluting Stent Implantation
- 1 May 2010
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation: Cardiovascular Quality and Outcomes
- Vol. 3 (3) , 261-266
Abstract
Background— Adjuvant clopidogrel therapy is essential after drug-eluting stent (DES) implantation. The frequency with which patients delay filling a clopidogrel prescription after DES implantation and the association of this delay with adverse outcomes is unknown. Methods and Results— This was a retrospective cohort study of patients discharged after DES implantation from 3 large integrated health care systems. Filling a clopidogrel prescription was based on pharmacy dispensing data. The primary end point was all-cause mortality or myocardial infarction (MI). Of 7402 patients discharged after DES implantation, 16% (n=1210) did not fill a clopidogrel prescription on day of discharge and the median time delay was 3 days (interquartile range, 1 to 23 days). Compared with patients filling clopidogrel on day of discharge, patients with any delay in filling clopidogrel had higher death/MI rates during follow-up (14.2% versus 7.9%; P 1, >3, or >5 days after discharge. Factors associated with delay included older age, prior MI, diabetes, renal failure, prior revascularization, cardiogenic shock, in-hospital bleeding, and clopidogrel use within 24 hours of admission. Conclusions— One in 6 patients delay filling their index clopidogrel prescription after hospital discharge after DES implantation. This delay was associated with increased risk of adverse outcomes and highlights the importance of the transition period from hospital discharge to outpatient setting as a potential opportunity to improve care delivery and patient outcomes.Keywords
This publication has 17 references indexed in Scilit:
- Cardiovascular Outcomes after a Change in Prescription Policy for ClopidogrelNew England Journal of Medicine, 2008
- Clinical, procedural, and pharmacologic correlates of acute and subacute stent thrombosis: Results of a multicenter case-control study with 145 thrombosis eventsAmerican Heart Journal, 2008
- Prevalence, Predictors, and Outcomes of Primary Nonadherence After Acute Myocardial InfarctionCirculation, 2008
- Restrictive access to clopidogrel and mortality following coronary stent implantationCanadian Medical Association Journal, 2008
- Risk Factors for Stent Thrombosis After Implantation of Sirolimus-Eluting Stents in Diabetic and Nondiabetic PatientsJACC, 2007
- Impact of Medication Therapy Discontinuation on Mortality After Myocardial InfarctionArchives of internal medicine (1960), 2006
- Prevalence, Predictors, and Outcomes of Premature Discontinuation of Thienopyridine Therapy After Drug-Eluting Stent PlacementCirculation, 2006
- Posthospital Medication DiscrepanciesArchives of internal medicine (1960), 2005
- Patients' Understanding of Their Treatment Plans and Diagnosis at DischargeMayo Clinic Proceedings, 2005
- Incidence, Predictors, and Outcome of Thrombosis After Successful Implantation of Drug-Eluting StentsJAMA, 2005